Showing 1751-1760 of 10612 results for "".
DKA in Focus: What the New Consensus Means for Practice
https://reachmd.com/programs/cme/dka-new-consensus-practice/50979/If widespread use of continuous ketone monitoring (CKM) devices is to be safe and effective in reducing the occurrence of diabetic ketoacidosis (DKA), it is important to establish clear ketone thresholds which notify CKM users when action on their part is required. In preparation for availability anDKA in the Real World: Evidence and Cases that Matter
https://reachmd.com/programs/cme/dka-real-world-evidence-cases/50981/Recently, an international panel of experts developed objective practical recommendations on how continuous ketone monitoring could improve diabetes care. Even more recently, new data was presented on the prevalence, risk, burden, and management of DKA. Join worldwide experts as they discuss the praKeeping CALM in Crohn’s Disease: An Exploration of Biomarker Cutoffs & Endoscopic Outcomes
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/keeping-calm-in-crohns-disease-an-exploration-of-biomarker-cutoffs-and-endoscopic-outcomes/12434/What does the CALM study tell us about biomarker cutoffs and endoscopic outcomes in Crohn’s disease?How Biosimilars Can Enhance the Lives—and Savings—of Rheumatoid Arthritis Patients
https://reachmd.com/programs/clinicians-roundtable/how-biosimilars-can-enhance-the-livesand-savingsof-rheumatoid-arthritis-patients/27068/Dive into a study focused on biosimilars and why they could be integral to treating patients with rheumatoid arthritis.Potassium Channel Opener Promising for Seizure Freedom
https://reachmd.com/programs/practical-neurology/potassium-channel-opener-promising-for-seizure-freedom/49196/Enhancing Collaborative Care in Retinal Diseases: A Focus on Injection Therapies
https://reachmd.com/programs/cme/enhancing-collaborative-care-in-retinal-diseases-a-focus-on-injection-therapies/37715/Explore strategies to improve retinal disease referrals and adherence to anti-VEGF therapy through interdisciplinary collaboration.Revolutionizing Aesthetic Medicine and Dermatology with Artificial Intelligence
https://reachmd.com/ma-issues-index/2025-mar-apr/revolutionizing-aesthetic-medicine-and-dermatology-with-artificial-intelligence/36064/This article explores the possibilities of AI and how it can be ethically utilized to enhance aesthetic medicine and marketing to grow one’s practice to its maximum potential.Treatment Response Assessment Tools for Relapsing Multiple Sclerosis
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/treatment-response-assessment-tools-for-relapsing-multiple-sclerosis/33142/The authors explore available tools for assessing treatment response in relapsing multiple sclerosis and provide practical recommendations for their use in clinical practice.Unmet Need: Second-Line Outcomes Remain Poor for NSCLC and Pancreatic Cancer
https://reachmd.com/programs/cme/unmet-need-second-line-outcomes-remain-poor-for-nsclc-and-pancreatic-cancer/54118/Explore ON-state RAS inhibitors for the treatment of NSCLC and pancreatic cancer, including mechanisms, efficacy data, and integration into clinical practice.Mechanistic Evolution in RAS Therapy: ON-State and Multi-Selective Targeting
https://reachmd.com/programs/cme/mechanistic-evolution-in-ras-therapy-on-state-and-multi-selective-targeting/54120/Explore ON-state RAS inhibitors for the treatment of NSCLC and pancreatic cancer, including mechanisms, efficacy data, and integration into clinical practice.